Respituss Dosage & Drug Information

Concise Prescribing Info Bahasa Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Contraindications Special Precautions Adverse Reactions Drug Interactions Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Concise Prescribing Info

Contents

Levodropropizine

Indications/Uses

Symptomatic treatment of cough in adults & childn >12 yr.

Click to view Respituss detailed prescribing information

Dosage/Direction for Use

Adult & childn >12 yr 10 mL up to 3 times daily at least 6 hrly. Treatment duration: Max: 7 days.

Click to view Respituss detailed prescribing information

Administration

Should be taken on an empty stomach.

Contraindications

Hypersensitivity. Excessive mucus discharge; limited mucociliary function (eg, Kartagener's syndrome, ciliary dyskinesia); bronchorrhoea. Severe hepatic impairment. Pregnancy & lactation.

Click to view Respituss detailed prescribing information

Special Precautions

Diabetic patients. Should only be used for short-term (max: 14 days). May affect ability to drive or use machines. Serious renal insufficiency. Childn <24 mth. Elderly.

Click to view Respituss detailed prescribing information

Adverse Reactions

Nausea, vomiting, heartburn, abdominal discomfort, diarrhea; exhaustion, faintness, somnolence, clouding of consciousness, numbness, dizziness, headache; palpitations; hypersensitivity reactions.

Click to view Respituss detailed prescribing information

Drug Interactions

Concomitant use w/ sedatives in sensitive individuals.

Click to view Respituss detailed prescribing information

Storage

View Respituss storage conditions for details to ensure optimal shelf-life.

Description

View Respituss description for details of the chemical structure and excipients (inactive components).

Action

View Respituss mechanism of action for pharmacodynamics and pharmacokinetics details.

MIMS Class

Cough & Cold Preparations

ATC Classification

R05DB27 - levodropropizine ; Belongs to the class of other cough suppressants.

Regulatory Classification

Presentation/Packing

Form

Respituss syr 30 mg/5 mL

Packing/Price

120 mL x 1's

Respituss

levodropropizine

Manufacturer:

Interbat